Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARGAN INC
Report date October 08, 2024 · Filed December 13, 2024
Section 16 reporting ended · disclosed 2024-12-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectMITENCO LLC | 2,500 |
Reported balance
Holding disclosure · report date 2024-10-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,500 |
| Common StockSEC Table I · non-derivative | IndirectMMAB LLC | 7,500 |
Reported balance
Holding disclosure · report date 2024-10-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 7,500 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-10-08 | Direct | 41,500 |
Reported balance
Holding disclosure · report date 2024-10-08 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 41,500 F1: Mr. Mitchell, a member of the Board of Directors of Argan, Inc., passed away on October 8, 2024. Mr. Mitchell held non-qualified stock option awards covering 41,500 shares of common stock of the Issuer, that are exercisable by his estate until October 8, 2025, at prices that range from $35.72 per share to $71.75 per share. |
| Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-12-16 | Direct | 6,000 |
Reported balance
Holding disclosure · report date 2024-10-08 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 6,000 F2: Mr. Mitchell also held restricted stock units covering a total of 6,000 shares of the common stock of the Issuer that will become issuable to his estate on dates that range from December 14, 2024 through December 14, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Mitchell, a member of the Board of Directors of Argan, Inc., passed away on October 8, 2024. Mr. Mitchell held non-qualified stock option awards covering 41,500 shares of common stock of the Issuer, that are exercisable by his estate until October 8, 2025, at prices that range from $35.72 per share to $71.75 per share.
F2: Mr. Mitchell also held restricted stock units covering a total of 6,000 shares of the common stock of the Issuer that will become issuable to his estate on dates that range from December 14, 2024 through December 14, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 19, 2024 Filed Apr 23, 2024 20:32 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,507 | $61.48 | $154,130.36 |
DisclosureSEC source: 0001415889-24-011373 · form4-04232024_080454.xml · nonDerivative · entry 1 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · MITENCO LLC Disclosed balance after: 2,500 F1 · shares: On April 19, 2024, the Reporting Person sold 2,507 shares of the Issuer's Common Stock on the open market at a price of $61.48 per share. Read SEC document |
| April 18, 2024 Filed Apr 19, 2024 20:24 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 190 | $60.35 | $11,466.50 |
DisclosureSEC source: 0001415889-24-011226 · form4-04192024_080437.xml · nonDerivative · entry 4 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · MITENCO LLC Disclosed balance after: 5,007 F4 · shares: On April 18, 2024, the Reporting Person sold 190 shares of the Issuer's Common Stock on the open market at a price of $60.35. Read SEC document |
| April 17, 2024 Filed Apr 19, 2024 20:24 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0001415889-24-011226 · form4-04192024_080437.xml · derivative · entry 7 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,500 Underlying: Common Stock · 10,000 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On April 17, 2024, the Reporting Person exercised his stock option awarded on December 12, 2018 to purchase 10,000 shares of the Issuer's Common Stock at a price of $41.19 per share. Read SEC document |
| April 17, 2024 Filed Apr 19, 2024 20:24 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 6,667 | $0.00 Strike: $46.35 | $0.00 |
DisclosureSEC source: 0001415889-24-011226 · form4-04192024_080437.xml · derivative · entry 6 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,500 Underlying: Common Stock · 6,667 shares Expires 2028-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 17, 2024, the Reporting Person exercised his stock option awarded on January 11, 2018 to purchase 6,667 shares of the Issuer's Common Stock at a price of $46.35 per share. Read SEC document |
| April 17, 2024 Filed Apr 19, 2024 20:24 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 13,143 | $60.17 | $790,814.31 |
DisclosureSEC source: 0001415889-24-011226 · form4-04192024_080437.xml · nonDerivative · entry 3 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · MITENCO LLC Disclosed balance after: 5,197 F3 · shares: On April 17, 2024 the Reporting Person sold 13,143 shares of the Issuer's Common Stock on the open market at an average price of $60.17 per share. Read SEC document |
| April 17, 2024 Filed Apr 19, 2024 20:24 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 3,338 | $41.19 | $137,492.22 |
DisclosureSEC source: 0001415889-24-011226 · form4-04192024_080437.xml · nonDerivative · entry 2 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · MITENCO LLC Disclosed balance after: 18,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On April 17, 2024, the Reporting Person exercised his stock option awarded on December 12, 2018 to purchase 10,000 shares of the Issuer's Common Stock at a price of $41.19 per share. Read SEC document |
| April 17, 2024 Filed Apr 19, 2024 20:24 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,669 | $46.35 | $77,358.15 |
DisclosureSEC source: 0001415889-24-011226 · form4-04192024_080437.xml · nonDerivative · entry 1 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · MITENCO LLC Disclosed balance after: 15,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 17, 2024, the Reporting Person exercised his stock option awarded on January 11, 2018 to purchase 6,667 shares of the Issuer's Common Stock at a price of $46.35 per share. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:17 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-016620 · form4-12182023_101213.xml · derivative · entry 2 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,500 shares Expires 2026-12-14 F2 · shares: On December 14, 2023, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 2,500 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 12/14/2024. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:17 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 1,500 | $0.00 Strike: $43.70 | $0.00 |
DisclosureSEC source: 0001415889-23-016620 · form4-12182023_101213.xml · derivative · entry 1 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,167 Underlying: Common Stock · 1,500 shares Expires 2033-12-14 F1 · shares: On December 14, 2023, the Reporting Person received 10-year options to purchase 1,500 shares of the Issuer's common stock with an exercise price of $43.70 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/14/2024. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012848 · form4-12202022_041217.xml · derivative · entry 2 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 1,750 shares Expires 2025-12-16 F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025. F5 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting Person includes (a) 1,750 shares of TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $35.72 | $0.00 |
DisclosureSEC source: 0001415889-22-012848 · form4-12202022_041217.xml · derivative · entry 1 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,667 Underlying: Common Stock · 5,000 shares Expires 2032-12-16 F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (b) 6,667 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with an initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (f) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and F3 · balance_after: (g) 5,000 shares of common stock at a price of $35.72 per share with an initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 14, 2021 Filed Dec 21, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-006154 · form4-12212021_041205.xml · derivative · entry 4 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2024-12-14 F4 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024. Read SEC document |
| December 14, 2021 Filed Dec 21, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $37.13 | $0.00 |
DisclosureSEC source: 0001415889-21-006154 · form4-12212021_041205.xml · derivative · entry 3 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,667 Underlying: Common Stock · 5,000 shares Expires 2031-12-14 F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (b) 6,667 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with an initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and F3 · balance_after: (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:28 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 15,000 | $52.60 | $789,000.00 |
DisclosureSEC source: 0001104659-21-053839 · tm2113788-1_4seq1.xml · nonDerivative · entry 1 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Through MITENCO LLC Disclosed balance after: 13,333 F1 · shares: On April 20, 2021, MITENCO LLC, an entity controlled by the Reporting Person, sold 15,000 shares of the Issuer's Common stock in the open market at an average price of $52.60 per share. F2 · ownership.nature: Previously, these shares were directly owned by the Reporting Person. The shares were subsequently contributed to MITENCO, LLC. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $45.75 | $0.00 |
DisclosureSEC source: 0001104659-20-136289 · tm2038593-1_4seq1.xml · derivative · entry 3 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,667 Underlying: Common Stock · 10,000 shares Expires 2030-12-14 F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's Common stock at a price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date beginning 12/14/2021. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (b) 6,667 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with an initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 16:13 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $40.15 | $0.00 |
DisclosureSEC source: 0001104659-19-075976 · a4.xml · derivative · entry 3 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,667 Underlying: Common Stock · 10,000 shares Expires 2029-12-23 F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (b) 6,667 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration date of 12/12/2028; and (d) options to acquire 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable beginning on 12/23/2020 and Expiration Date of 12/23/2029. Read SEC document |
| April 26, 2019 Filed Apr 26, 2019 20:24 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 17,212 | $49.27 | $848,035.24 |
DisclosureSEC source: 0001104659-19-024087 · a4.xml · nonDerivative · entry 3 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,333 F4 · shares: On April 26, 2019, the Reporting Person sold 17,212 shares of the Issuer's common stock on the open market at an average price of $49.27 per share. Read SEC document |
| April 25, 2019 Filed Apr 26, 2019 20:24 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 7,788 | $49.73 | $387,297.24 |
DisclosureSEC source: 0001104659-19-024087 · a4.xml · nonDerivative · entry 2 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,545 F3 · shares: On April 25, 2019, the Reporting Person sold 7,788 shares of the Issuer's common stock on the open market at an average price of $49.73 per share. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 20:24 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 53,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-024087 · a4.xml · derivative · entry 5 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,667 Underlying: Common Stock · 53,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023; F2 · derivative.exercise_price: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94. F1 · shares: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023; F2 · shares: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94. F1 · derivative.exercise_date: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023; F2 · derivative.exercise_date: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94. F1 · derivative.expiration_date: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023; F2 · derivative.expiration_date: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94. F1 · derivative.underlying_shares: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023; F2 · derivative.underlying_shares: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94. F5 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (i) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (ii) 6,667 shares of common stock at a price of $46.35 per share, subject to a three-year ratably vesting schedule, with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (iii) options to acquire shares of common stock at a price of $41.19 per share, subject to a three-year ratably vesting schedule, with initial Date Exercisable beginning on 12/12/2019 and Expiration date of 12/12/2028. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 20:24 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 53,333 | $25.94 | $1,383,458.02 |
DisclosureSEC source: 0001104659-19-024087 · a4.xml · nonDerivative · entry 1 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023; F2 · shares: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94. Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 21:06 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0001104659-18-073087 · a4.xml · derivative · entry 2 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 10,000 shares Expires 2028-12-12 F1 · shares: On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (i) 5,000 shares of Common Stock at an Exercise Price of $12.43 per share with Date Exercisable of 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of Common Stock at an Exercise Price of $17.33 per share with Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (v) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; F3 · balance_after: (vi) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (vii) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (viii) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (ix) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 21:10 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $46.35 | $0.00 |
DisclosureSEC source: 0001104659-18-002379 · a4.xml · derivative · entry 2 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 10,000 shares Expires 2028-01-11 F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (i) 5,000 shares of Common Stock at an Exercise Price of $12.43 per share with Date Exercisable of 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of Common Stock at an Exercise Price of $17.33 per share with Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (v) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; F3 · balance_after: (vi) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (vii) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; and (viii) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. Read SEC document |
| January 05, 2017 Filed Mar 1, 2017 02:13 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $71.75 | $0.00 |
DisclosureSEC source: 0001104659-17-012736 · a4.xml · derivative · entry 2 MITCHELL W G CHAMPION · CIK 0001204823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 10,000 shares Expires 2027-01-05 F2 · shares: Pursuant to a stock option agreement dated January 5, 2017, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $71.75 per share. F3 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (i) 5,000 shares of Common Stock at an Exercise Price of $12.43 per share with Date Exercisable of 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of Common Stock at an Exercise Price of $17.33 per share with Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (v) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; F4 · balance_after: (vi) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.